CapsoVision, Inc. (CV) vs Treace Medical Concepts, Inc. (TMCI)
CapsoVision, Inc. and Treace Medical Concepts, Inc. are both Medical Devices companies. CapsoVision, Inc. is the larger, with a market value of $328.3M against $295.3M — 1.1× the size. Treace Medical Concepts, Inc. has negative trailing earnings, so its P/E is not meaningful; CapsoVision, Inc. trades at 2.1×. CapsoVision, Inc. grew revenue faster over the last twelve months: 16.7% against −3.95%. Treace Medical Concepts, Inc. has the higher net margin (−29.0% vs −214.7%) and the higher return on invested capital (−43.0% vs −460.9%). Across the 17 metrics below, Treace Medical Concepts, Inc. leads on 10 and CapsoVision, Inc. on 7.
Valuation
Profitability
| Metric | CV | TMCI | Medical Devices median |
|---|---|---|---|
| Gross margin | 50.88% | 79.45% | 56.01% |
| Operating margin | (217.09%) | (26.17%) | (15.03%) |
| Net margin | (214.74%) | (28.99%) | (20.40%) |
| Free cash flow margin | (200.77%) | (12.20%) | (7.24%) |
| Return on equity | 47.42% | (71.99%) | (15.32%) |
| Return on assets | (212.19%) | (30.72%) | (19.72%) |
| Return on invested capital | (460.93%) | (42.96%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack